<DOC>
	<DOCNO>NCT02779582</DOCNO>
	<brief_summary>This study design evaluate within-woman effect oral micronized progesterone ( Progesterone 300 mg bedtime ) semi-quantitative menstrual flow measure DivaCup® ( menstrual cup volume indicator 7.5 , 15 30 ml ) count number soak normal-sized sanitary product normal-sized tampon pad well length flow frequency severity menstrual cramp ( 0-4 scale ) woman hot flush night sweat qualify enroll primary perimenopausal hot flush trial stratify whether Early Late Perimenopause .</brief_summary>
	<brief_title>Oral Micronized Progesterone Effects Perimenopausal Menstrual Flow</brief_title>
	<detailed_description>The study double-masked , placebo-controlled 28-day ( 4 week ) baseline , 84-day ( 12 week ) experimental trial , maximum number 125 potential enrollee , stratify random therapy assignment Early Late Perimenopause . Participants meet inclusion criterion original Progesterone Perimenopausal Vasomotor Symptoms Study invite join additional sub-study . As part primary trial randomly assign either Progesterone placebo group 1:1 basis . Primary secondary data collect continuously throughout study completion Daily Perimenopause Diary-flow start baseline continuously throughout study .</detailed_description>
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>&gt; 35 &lt; 58 year age Willingness participate substudy Perimenopausal status either base irregularity menstrual period , onset hot flushes/night sweat woman regular period Ability willingness complete flow record instrument Ability understand , speak , read write English . Less 35 great 58 year age More 1yr without menstrual flow study enrollment , include hysterectomy ± ovariectomy Peanut allergy ( peanut oil use progesterone formulation ) Current recent ( within 6mo study enrollment ) use hormonal therapy ( estrogen , progesterone , progestinreleasing intrauterine device ( IUD ) , hormonal contraceptive , hormonal fertility treatment ) , plan initiate use study period Planned pregnancy fertility treatment study period Inability understand , speak , read write English</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>58 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Progesterone</keyword>
	<keyword>Menstrual Flow</keyword>
</DOC>